Comparison of diet and exercise on cardiometabolic factors in young adults with overweight/obesity: multiomics analysis and gut microbiota prediction, a randomized controlled trial

Abstract

The optimal strategy for improving cardiometabolic factors (CMFs) in young obese individuals through diet and exercise remains unclear, as do the potential mechanisms. We conducted an 8-week randomized controlled trial to compare the effects of different interventions in youth with overweight/obesity. Gut microbes and serum metabolites were examined to identify regulating mechanisms. A total of 129 undergraduates were randomly assigned to fiber-rich (FR) diet, rope-skipping (RS), combined FR–RS and control groups. The results showed that single interventions were as effective as combined interventions in improving weight, waist circumference, body fat, and lipid profile compared with control group. Notably, the FR group further reduced low-density lipoprotein (LDL-C) and uric acid (UA) (all p < 0.05). Mediation analysis revealed four gut microbiota–metabolite–host axes in improving CMFs. Additionally, we used machine learning algorithms to further predict individual responses based on baseline gut microbiota composition, with specific microbial genera guiding targeted intervention selection. In conclusion, FR diet and/or RS were effective in improving CMFs, with the FR diet particular effectiveness in reducing LDL-C and UA levels. These benefits may drive by gut microbiome–metabolite–host interactions. Moreover, the predictability of gut microbiota composition supports making targeted decisions in selecting interventions. Trial Registration: NCT04834687.

Keywords

aerobic exercise / cardiometabolic factors / fiber-rich diet / gut microbiota / prediction / young adults

References

[1] Sacco RL, Roth GA, Reddy KS, et al. The heart of 25 by 25: achieving the goal of reducing global and regional premature deaths from cardiovascular diseases and stroke: a modeling study from the American Heart Association and World Heart Federation. Circulation. 2016; 133(23): e674-90.

[2] Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019; 16(4): 203-212.

[3] Andersson C, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol. 2018; 15(4): 230-240.

[4] China TWCotRoCHaDi. Interpretation of report on cardiovascular health and diseases in China 2020. Chin J Cardiovasc Med. 2021; 26(3): 209-218.

[5] Ren J, Guo XL, Lu ZL, et al. Ideal cardiovascular health status and its association with socioeconomic factors in Chinese adults in Shandong, China. BMC Public Health. 2016; 16(1): 942.

[6] Du H, van der AD, Boshuizen HC, et al. Dietary fiber and subsequent changes in body weight and waist circumference in European men and women. Am J Clin Nutr. 2010; 91(2): 329-336.

[7] Birketvedt GS, Shimshi M, Erling T, Florholmen J. Experiences with three different fiber supplements in weight reduction. Med Sci Monit. 2005; 11(1): Pi5-Pi8.

[8] Kovatcheva-Datchary P, Nilsson A, Akrami R, et al. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of prevotella. Cell Metab. 2015; 22(6): 971-982.

[9] Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999; 69(1): 30-42.

[10] Anderson JW, Randles KM, Kendall CW, Jenkins DJ. Carbohydrate and fiber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr. 2004; 23(1): 5-17.

[11] Jin L, Shi X, Yang J, et al. Gut microbes in cardiovascular diseases and their potential therapeutic applications. Protein Cell. 2021; 12(5): 346-359.

[12] Makki K, Deehan EC, Walter J, Bäckhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018; 23(6): 705-715.

[13] Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016; 165(6): 1332-1345.

[14] Kern T, Blond MB, Hansen TH, et al. Structured exercise alters the gut microbiota in humans with overweight and obesity-A randomized controlled trial. Int J Obes (2005). 2020; 44(1): 125-135.

[15] Bressa C, Bailén-Andrino M, Pérez-Santiago J, et al. Differences in gut microbiota profile between women with active lifestyle and sedentary women. PLoS One. 2017; 12(2): e0171352.

[16] Gardner CD, Trepanowski JF, Del Gobbo LC, et al. Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion: the DIETFITS randomized clinical trial. JAMA. 2018; 319(7): 667-679.

[17] Berry SE, Valdes AM, Drew DA, et al. Human postprandial responses to food and potential for precision nutrition. Nat Med. 2020; 26(6): 964-973.

[18] Salinardi TC, Batra P, Roberts SB, et al. Lifestyle intervention reduces body weight and improves cardiometabolic risk factors in worksites. Am J Clin Nutr. 2013; 97(4): 667-676.

[19] Estruch R, Martínez-González MA, Corella D, et al. Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk. J Epidemiol Community Health. 2009; 63(7): 582-588.

[20] Ho SS, Dhaliwal SS, Hills AP, Pal S. The effect of 12 weeks of aerobic, resistance or combination exercise training on cardiovascular risk factors in the overweight and obese in a randomized trial. BMC Public Health. 2012; 12: 704.

[21] Pontzer H, Yamada Y, Sagayama H, et al. Daily energy expenditure through the human life course. Science. 2021; 373(6556): 808-812.

[22] Jie Z, Xia H, Zhong SL, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017; 8(1): 845.

[23] Estaki M, Pither J, Baumeister P, et al. Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions. Microbiome. 2016; 4(1): 42.

[24] Dhakal S, McCormack L, Dey M. Association of the gut microbiota with weight-loss response within a retail weight-management program. Microorganisms. 2020; 8(8).

[25] Fung TC, Vuong HE, Luna CDG, et al. Intestinal serotonin and fluoxetine exposure modulate bacterial colonization in the gut. Nat Microbiol. 2019; 4(12): 2064-2073.

[26] Lynch JB, Gonzalez EL, Choy K, et al. Gut microbiota Turicibacter strains differentially modify bile acids and host lipids. Nat Commun. 2023; 14(1): 3669.

[27] Pinart M, Dötsch A, Schlicht K, et al. Gut microbiome composition in obese and non-obese persons: a systematic review and meta-analysis. Nutrients. 2021; 14(1): 12.

[28] Rodriguez J, Neyrinck AM, Van Kerckhoven M, et al. Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individuals. BMC Med. 2022; 20(1): 110.

[29] Liu C, Du P, Cheng Y, et al. Study on fecal fermentation characteristics of aloe polysaccharides in vitro and their predictive modeling. Carbohydr Polym. 2021; 256: 117571.

[30] Xiao C, Wang JT, Su C, et al. Associations of dietary diversity with the gut microbiome, fecal metabolites, and host metabolism: results from 2 prospective Chinese cohorts. Am J Clin Nutr. 2022; 116(4): 1049-1058.

[31] Cho KY. Lifestyle modifications result in alterations in the gut microbiota in obese children. BMC Microbiol. 2021; 21(1): 10.

[32] López-Montoya P, Cerqueda-García D, Rodríguez-Flores M, et al. Association of gut microbiota with atherogenic dyslipidemia, and its impact on serum lipid levels after bariatric surgery. Nutrients. 2022; 14(17): 3545.

[33] Feng J, Ma H, Huang Y, Li J, Li W. Ruminococcaceae_UCG-013 promotes obesity resistance in mice. Biomedicines. 2022; 10(12): 3272.

[34] Zhang X, Wu X, Xiao G, et al. Phenolamide extract of apricot bee pollen alleviates glucolipid metabolic disorders and modulates the gut microbiota and metabolites in high-fat diet-induced obese mice. Food Funct. 2023; 14(10): 4662-4680.

[35] Pieczyńska-Zając JM, Malinowska AM, Pruszyńska-Oszmałek E, Kołodziejski PA, Drzymała-Czyż S, Bajerska J. Effect of a high-fat high-fructose diet on the composition of the intestinal microbiota and its association with metabolic and anthropometric parameters in a letrozole-induced mouse model of polycystic ovary syndrome. Nutrition (Burbank, Los Angeles County, Calif). 2024; 124: 112450.

[36] Gao X, Chang S, Liu S, et al. Correlations between α-linolenic acid-improved multitissue homeostasis and gut microbiota in mice fed a high-fat diet. mSystems. 2020; 5(6): e00391.

[37] Abdi F, Mohammadzadeh M, Abbasalizad-Farhangi M. Dietary amino acid patterns and cardiometabolic risk factors among subjects with obesity; a cross-sectional study. BMC Endocr Disord. 2024; 24(1): 21.

[38] Ejtahed HS, Hasani-Ranjbar S, Larijani B. Human microbiome as an approach to personalized medicine. Altern Ther Health Med. 2017; 23(6): 8-9.

[39] Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444(7122): 1022-1023.

[40] Le Roy T, Llopis M, Lepage P, et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut. 2013; 62(12): 1787-1794.

[41] Deehan EC, Yang C, Perez-Muñoz ME, et al. Precision microbiome modulation with discrete dietary fiber structures directs short-chain fatty acid production. Cell Host Microbe. 2020; 27(3): 389-404. e6.

[42] Li Y, Hong G, Yang M, et al. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome. Pharmacol Res. 2020; 159: 104936.

[43] Xin FZ, Zhao ZH, Liu XL, et al. Escherichia fergusonii promotes nonobese nonalcoholic fatty liver disease by interfering with host hepatic lipid metabolism through its own msRNA 23487. Cell Mol Gastroenterol Hepatol. 2022; 13(3): 827-841.

[44] Rau M, Rehman A, Dittrich M, et al. Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease. United European Gastroenterol J. 2018; 6(10): 1496-1507.

[45] Wang K, Liao M, Zhou N, et al. Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep. 2019; 26(1): 222-235. e5.

[46] Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016; 65(2): 330-339.

[47] Wang S, Zhang L, Wang D, et al. Gut microbiota composition is associated with responses to peanut intervention in multiple parameters among adults with metabolic syndrome risk. Mol Nutr Food Res. 2021; 65(18): e2001051.

[48] Jianhua H. Effect on 8 weeks diet and exercise intervention on physiological parameters, blood lipid and insulin of obese female college students [Chinese]. Zhejiang Sport Sci. 2013; 35(4): 124-128.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.